TELEFLEX INC
Close on Oct 19, 2026
- Market cap
- $5.66B
- P/E (TTM)
- –
- Dividend yield
- 1.05%
About Teleflex
Surgical & Medical Instruments & Apparatus, SIC 3841
Teleflex Incorporated designs, develops, manufactures, and supplies medical technology products, concentrating primarily on single-use devices for critical care and surgical applications. Its core product categories comprise vascular and emergency medicine, interventional devices, and surgical instruments, including catheters, intraosseous access systems, hemostatic products, vascular closure devices, and ligating clips. The company operates through three reportable segments: Americas, EMEA, and Asia. Teleflex markets and sells these items to hospitals and healthcare providers globally through direct sales personnel, independent representatives, and distributor networks.
The company operates globally, with major manufacturing facilities in the Czech Republic, Malaysia, Mexico, and the United States. As of December 31, 2025, Teleflex employed approximately 15,500 people, comprising 3,700 workers in the United States and 11,800 across 38 other nations. The provided text details international commercial operations and supply chains across these territories, though it does not state the company's specific headquarters location.
Summary of the business section of Teleflex's latest annual report, written by StockData.
Company profile
Company
- Legal name
- TELEFLEX INC
- Founded
- 1943
- Headquarters
- Wayne, PA
- Address
- 550 E Swedesford Rd, Suite 400 19087
- Phone
- (610) 225-6800
- Website
- www.teleflex.com
- Employees
- 15,500, Dec 31, 2025
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- PricewaterhouseCoopers LLP, Philadelphia, Pennsylvania
Stock & identifiers
- Ticker
- TFX
- Exchange
- NYSE
- Shares outstanding
- 42M, Aug 4, 2026
- Public float
- $2.30B, Jun 29, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 2-for-1, Jun 17, 1997; 3-for-2, Jun 17, 1991; 2-for-1, Jun 17, 1986; 3-for-2, Sep 16, 1981; 2-for-1, Dec 16, 1980
- SEC CIK
- 96943
- CUSIP
- 879369106
- ISIN
- US8793691069
- LEI
- UUL85LWXB4NGSWWXIQ25
- EIN
- 23-1147939
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Jason R. Weidman | President and CEO, Director | 53,983 |
| Liam Kelly | Chairman, President & CEO, Director | 64,584 |
| Dominik Michal Reterski | Corporate Vice President, QARA | 7,198 |
| John Deren | Executive Vice President & CFO | 18,077 |
| Cameron P. Hicks | Corp. VP & Chief HR Officer | 19,400 |
| James Winters | Corp VP, Mfg and Supply | 17,760 |
| Daniel V. Logue | CVP, General Counsel & Secty | 24,959 |
| Thomas E. Powell | Executive Vice President & CFO | 21,865 |
| Jay White | CVP & Pres, Global Commercial | 9,218 |
| Sean Salmon | Director | 674 |
| Stuart A. Randle | Director | 16,524 |
| Michael J. Tokich | Director | 1,090 |
| Candace H. Duncan | Director | 7,039 |
| Gretchen R. Haggerty | Director | 7,395 |
| Neena M. Patil | Director | 3,716 |
| Andrew A. Krakauer | Director | 8,309 |
| Jaewon Ryu | Director | 4,817 |
| John C. Heinmiller | Director | 5,040 |
| Stephen K. M.D. Klasko | Director | 17,213 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Liam J. Kelly | $6.73M | $1.84M | $1.70M | $31 | $123 |
| FY2024 Liam J. Kelly | $9.20M | $2.74M | $2.52M | $48 | $135 |
| FY2023 Liam J. Kelly | $9.04M | $9.26M | $2.33M | $67 | $123 |
| FY2022 Liam J. Kelly | $8.19M | $5.01M | $2.05M | $67 | $112 |
| FY2021 Liam J. Kelly | $8.67M | $4.24M | $2.07M | $88 | $142 |
| FY2020 Liam J. Kelly | $6.33M | $4.83M | $1.60M | $110 | $119 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we employed approximately 15,500 employees, including 3,700 employees in the U.S.”
Corporate history
Events identified from SEC filings